During the past decade, Diakovere Henriettenstift, Frauenklinik conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Diakovere Henriettenstift, Frauenklinik" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "West German Study Group" with 2 trials sponsored, "Alliance Foundation Trials, LLC." with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diakovere Henriettenstift, Frauenklinik" #1 collaborator was "German Breast Group" with 3 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Breast Cancer Trials, Australia and New Zealand" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Diakovere Henriettenstift, Frauenklinik" are "Breast Cancer" (6 trials), "Breast Cancer Female" (1 trials), "Estrogen Receptor Positive Breast Cancer" (1 trials), "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials) and "Fallopian Tube Cancer" (1 trials). Many other conditions were trialed in "Diakovere Henriettenstift, Frauenklinik" in a lesser frequency.

Most popular intervention types in "Diakovere Henriettenstift, Frauenklinik" are "Drug" (14 trials), "Other" (3 trials), "Biological" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Pertuzumab" (3 trials), "Trastuzumab" (3 trials), "Atezolizumab" (2 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Diakovere Henriettenstift, Frauenklinik" are 10 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Diakovere Henriettenstift, Frauenklinik". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Diakovere Henriettenstift, Frauenklinik, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Diakovere Henriettenstift, Frauenklinik, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".